Explore the challenges of integrating continuous glucose monitoring (#CGM) and #wearables in clinical trials, along with recent breakthroughs offering new hope for patients. Download the Q&A article written by Susan Brumm, DNP, APRN, CNP, BC-ADM and Dipali Gupta, MS to learn about the critical importance of strong collaboration between the CRO, Core Lab, Sponsor, and patients in these trials: https://lnkd.in/eWHbQAAd
Medpace
Pharmaceutical Manufacturing
Cincinnati, OH 229,485 followers
Accelerating Drug, Biologic and Medical Device Clinical Development
About us
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 5,800 people across 41 countries.
- Website
-
http://www.medpace.com
External link for Medpace
- Industry
- Pharmaceutical Manufacturing
- Company size
- 5,001-10,000 employees
- Headquarters
- Cincinnati, OH
- Type
- Public Company
- Founded
- 1992
- Specialties
- Early Phase Clinical Research, Phase II-III Clinical Research, RWE-Late Phase Clinical Research, Medical Device and Diagnostics, Regulatory Affairs, Medical Writing, Clinical Monitoring, Clinical Trial Management, Biostatistics and Data Sciences, Drug Safety and Pharmacovigilance, Quality Assurance, Central Laboratories, Bioanalytical Laboratories, Imaging & ECG Core Labs, Oncology clinical development, Nephrology clinical development, Neuroscience clinical development, Infectious Disease clinical development, Cardiovascular clinical development, Metabolic and endocrine clinical development, Rare disease clinical development, Cell and gene therapy clinical development, and Radiopharmaceuticals
Locations
-
Primary
5375 Medpace Way
Cincinnati, OH 45227, US
Employees at Medpace
Updates
-
Are you a student working towards a degree in life science? Take a look at open internships available to students with backgrounds in life science. In the Medpace Internship Program, interns get hands-on experience working with some of the brightest minds in biotech. Apply today to jumpstart your work experience: https://bit.ly/3Y0ayns #workatmedpace #STEM #internship
-
In this recently published Q&A article, Professor Maciej Banach, Department of Preventive Cardiology and Lipidology at Medical University of Lodz, shares preliminary results of VERVE-101, a novel CRISPR-based gene editing technology, and its role in the lipid-lowering pathway. Read now to discover insights on new lipid-lowering treatments, safety concerns, and what recent clinical trials reveal about the effectiveness and future of these groundbreaking therapies: https://lnkd.in/drmBHvbB
Expert Insights: Q&A with Prof. Maciej Banach
medpace.com
-
We are thrilled to announce that Medpace has been recognized with the 2024 CRO Leadership Awards by Life Science Leader and Clinical Leader. Receiving awards in all five categories—Capabilities, Compatibility, Expertise, Quality, and Reliability—reaffirms our commitment to Making the Complex Seamless® for drug Sponsors. Our quality-focused operating model, high-caliber study teams, and integrated services and technology ensure operational excellence on a global scale from project onset to closeout. Learn more about how Medpace continues to lead in the clinical development industry in our latest blog post: https://lnkd.in/gMNHwCJt
-
-
"With the many innovations and advances in rheumatology, it is exciting to be a part of the development of these new therapies for patients," says Dr. Maricor Docena, Medical Director at Medpace. In this new video, Dr. Docena shares how Medpace's cross-therapeutic collaboration across immune-mediated inflammatory diseases provides the necessary medical expertise to optimize your trial design while ensuring expedited timelines. If you have an upcoming project that needs seamless execution, contact our #rheumatology experts: https://lnkd.in/gAxJq6Vu
-
Despite the recent biopharmaceutical slowdown, the emerging #biotech sector is at a pivotal point with renewed confidence. This edition of Seamless Clinical Insights explores the current biotech atmosphere, highlighting opportunities for 2024 and beyond. Medpace Chief Medical Officer, Dr. Reinilde Heyrman, states, "The age-old saying of failing to plan is planning to fail holds truth also in a dynamic landscape. At Medpace, we can help in planning to grasp the opportunities that present while maintaining the flexibility to turn on a dime when required." #Subscribe to our newsletter to gain actionable insights for your journey to clinical success.
Navigating Biotech's Future: Opportunities for 2024 and Beyond
Medpace on LinkedIn
-
In just over one month, Medpace headquarters will be welcoming members of the Cincinnati community to campus for the annual Medpace 5k! All proceeds of the event go to our partner, Best Point, to aid their their mission of supporting those facing mental health challenges. Sign up today to secure your spot at the starting line and claim your Medpace 5k t-shirt! https://bit.ly/3xCwTNd
-
Over the weekend, Medpace associates raced through the streets of Hyde Park for the Hyde Park Blast! Medpace is thrilled to once again be a Presenting Sponsor of the Hyde Park Blast in support of the fight against cancer with The Cure Starts Now. Not able to make this running event? Join us August 17th for the Medpace 5k! Register now to claim your spot: https://bit.ly/3xCwTNd #HydeParkBlast #Medpace5k
-
-
Today is World Scleroderma Day. Scleroderma is a rare, chronic autoimmune disease that affects skin and internal organs. Join us in raising awareness for #scleroderma and to advocate for those impacted by this life-threatening #rheumatic disease. Medpace is committed to accelerating rheumatology clinical development in order to improve the lives of people affected by autoimmune diseases, including scleroderma. Learn more about Medpace’s experience in #rheumatology: https://lnkd.in/gzQFP3MA
-
-
Join us today on International PKU Day in raising awareness for those living with phenylketonuria (PKU), a rare inherited disorder. Discover how our experienced cross-functional #RareDisease team of medical, operational, and regulatory experts accelerates complex clinical trials to improve the lives of individuals with PKU and other rare diseases: https://lnkd.in/g-ApFhTc #PKUDay2024 #Phenylketonuria
-
Similar pages
Browse jobs
Stock
MEDP
NASDAQ
20 minutes delay
$443.00
8.01 (1.841%)
- Open
- 436.22
- Low
- 431
- High
- 444.87
Data from Refinitiv
See more info on